Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philipp Mandel

Showing results (51-60 of 220) with videos related to

Pageof 22
Sort By:
European Urology Focus|September 4, 2022
Triplet or Doublet Therapy in Metastatic Hormone-sensitive Prostate Cancer Patients: A Systematic Review and Network Meta-analysisPhilipp Mandel, Benedikt Hoeh, Mike Wenzel, et al.
The Prostate|June 10, 2021
Twenty-year trends in prostate cancer stage and grade migration in a large contemporary german radical prostatectomy cohortChristoph Würnschimmel, Mykyta Kachanov, Mike Wenzel, et al.
The Journal of Urology|August 11, 2016
The Impact of Repeat Prostate Biopsies on Oncologic, Pathological and Perioperative Outcomes after Radical ProstatectomyClemens M Rosenbaum, Philipp Mandel, Pierre Tennstedt, et al.
European Urology Focus|April 13, 2023
Triplet or Doublet Therapy in Metastatic Hormone-sensitive Prostate Cancer: Updated Network Meta-analysis Stratified by Disease VolumeBenedikt Hoeh, Cristina Cano Garcia, Mike Wenzel, et al.
Urologia Internationalis|December 21, 2023
Metastatic Squamous Cell Carcinoma of the Urinary Bladder: Urgent Call for New TherapiesSéverine Banek, Benedikt Hoeh, Cristina Cano Garcia, et al.
European Urology Focus|July 9, 2026
Natural History of Patients Eligible for PROTEUS Diagnosed with Prostate Cancer and Treated with Radical Prostatectomy Without Perioperative Systemic TreatmentBenedikt Hoeh, Giovanni Mazzucato, Pierre Tennstedt, et al.
Medicina (Kaunas, Lithuania)|January 23, 2024
Cardiovascular Disease and Chronic Pulmonary Disease Increase the Risk of Short-Term Major Postoperative Complications after Robotic-Assisted Radical ProstatectomyCarolin Siech, Antonia Gruber, Mike Wenzel, et al.
Urologic Oncology|September 27, 2023
Patient and tumor characteristics of histological subtypes of renal cell carcinoma and its risk of upstaging to ≥pT3Mike Wenzel, Benedikt Hoeh, Cristina Cano Garcia, et al.
The Journal of Urology|February 21, 2017
Oncologic and Functional Outcomes after Radical Prostatectomy for High or Very High Risk Prostate Cancer: European Validation of the Current NCCN® GuidelineRaisa S Pompe, Pierre I Karakiewicz, Zhe Tian, et al.
The Journal of Urology|December 16, 2014
External validation of the CAPRA-S score to predict biochemical recurrence, metastasis and mortality after radical prostatectomy in a European cohortDerya Tilki, Philipp Mandel, Thorsten Schlomm, et al.
Pageof 22

Showing results (51-60 of 220) with videos related to

Sort By:
Pageof 22
European Urology Focus|September 4, 2022
Triplet or Doublet Therapy in Metastatic Hormone-sensitive Prostate Cancer Patients: A Systematic Review and Network Meta-analysisPhilipp Mandel, Benedikt Hoeh, Mike Wenzel, et al.
The Prostate|June 10, 2021
Twenty-year trends in prostate cancer stage and grade migration in a large contemporary german radical prostatectomy cohortChristoph Würnschimmel, Mykyta Kachanov, Mike Wenzel, et al.
The Journal of Urology|August 11, 2016
The Impact of Repeat Prostate Biopsies on Oncologic, Pathological and Perioperative Outcomes after Radical ProstatectomyClemens M Rosenbaum, Philipp Mandel, Pierre Tennstedt, et al.
European Urology Focus|April 13, 2023
Triplet or Doublet Therapy in Metastatic Hormone-sensitive Prostate Cancer: Updated Network Meta-analysis Stratified by Disease VolumeBenedikt Hoeh, Cristina Cano Garcia, Mike Wenzel, et al.
Urologia Internationalis|December 21, 2023
Metastatic Squamous Cell Carcinoma of the Urinary Bladder: Urgent Call for New TherapiesSéverine Banek, Benedikt Hoeh, Cristina Cano Garcia, et al.
European Urology Focus|July 9, 2026
Natural History of Patients Eligible for PROTEUS Diagnosed with Prostate Cancer and Treated with Radical Prostatectomy Without Perioperative Systemic TreatmentBenedikt Hoeh, Giovanni Mazzucato, Pierre Tennstedt, et al.
Medicina (Kaunas, Lithuania)|January 23, 2024
Cardiovascular Disease and Chronic Pulmonary Disease Increase the Risk of Short-Term Major Postoperative Complications after Robotic-Assisted Radical ProstatectomyCarolin Siech, Antonia Gruber, Mike Wenzel, et al.
Urologic Oncology|September 27, 2023
Patient and tumor characteristics of histological subtypes of renal cell carcinoma and its risk of upstaging to ≥pT3Mike Wenzel, Benedikt Hoeh, Cristina Cano Garcia, et al.
The Journal of Urology|February 21, 2017
Oncologic and Functional Outcomes after Radical Prostatectomy for High or Very High Risk Prostate Cancer: European Validation of the Current NCCN® GuidelineRaisa S Pompe, Pierre I Karakiewicz, Zhe Tian, et al.
The Journal of Urology|December 16, 2014
External validation of the CAPRA-S score to predict biochemical recurrence, metastasis and mortality after radical prostatectomy in a European cohortDerya Tilki, Philipp Mandel, Thorsten Schlomm, et al.
Pageof 22